A Retrospective Study Comparing the Efficacy of Dose-Dense Chemotherapy, Intraperitoneal Chemotherapy and Dose-Dense Chemotherapy with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Advanced Stage Ovarian Carcinoma

ConclusionWe observed PFS advantages conferred to the ovarian cancer patients treated with HIPEC and IP chemotherapy compared to DD chemotherapy. However, an overall survival advantage related to the chemotherapy regimens was not borne out, possibly due to the retrospective nature of the study or differing time periods wherein the specific patient cohorts underwent treatment.
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research